{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:21:45Z","timestamp":1740126105753,"version":"3.37.3"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T00:00:00Z","timestamp":1523664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T00:00:00Z","timestamp":1523664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1111\/bjd.16267","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T10:54:41Z","timestamp":1514112881000},"page":"1441-1442","source":"Crossref","is-referenced-by-count":5,"title":["Lymphoedema in patients with lentigo maligna treated with imiquimod: a long-term adverse effect"],"prefix":"10.1093","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-1612","authenticated-orcid":false,"given":"D.","family":"Tio","sequence":"first","affiliation":[{"name":"Vrije Universiteit Medical Center; Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kirtschig","sequence":"additional","affiliation":[{"name":"University Hospital of Marburg; Marburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hoekzema","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Medical Center; Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"van Montfrans","sequence":"additional","affiliation":[{"name":"Erasmus Universiteit Medical Center; Rotterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,14]]},"reference":[{"key":"10.1111\/bjd.16267-BIB0001|bjd16267-cit-0001","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jid.2016.06.014","article-title":"Epidemiology of lentigo maligna and lentigo maligna melanoma in the Netherlands, 1989-2013","volume":"136","author":"Greveling","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16267-BIB0002|bjd16267-cit-0002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.16267-BIB0003|bjd16267-cit-0003","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1046\/j.1365-2133.2000.03787.x","article-title":"Imiquimod: a novel treatment for lentigo maligna","volume":"143","author":"Ahmed","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16267-BIB0004|bjd16267-cit-0004","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjd.14311","article-title":"Five-year recurrence rate of lentigo maligna after treatment with imiquimod","volume":"174","author":"Kai","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16267-BIB0005|bjd16267-cit-0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/jdv.14085","article-title":"A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures","volume":"31","author":"Tio","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16267-BIB0006|bjd16267-cit-0006","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bjd.15112","article-title":"Effect of topical imiquimod as primary treatment for lentigo maligna - the LIMIT-1 study","volume":"176","author":"Marsden","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16267-BIB0007|bjd16267-cit-0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2340\/00015555-1861","article-title":"Twelve-week treatment of lentigo maligna with imiquimod results in a high and sustained clearance rate","volume":"95","author":"Kirtschig","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.16267-BIB0008|bjd16267-cit-0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000339613","article-title":"Wound repair and regeneration","volume":"49","author":"Reinke","year":"2012","journal-title":"Eur Surg Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16267","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16267\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:38:39Z","timestamp":1676381919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/6\/1441\/6687700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,14]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16267","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2018,4,14]]}}}